Mechanism of Gexia zhuyu decoction in the intervention of metabolic-associated fatty liver disease by inhibiting ferroptosis

ZHAO Yuqiang; WANG Ziyou; LI Anqi; ZHAO Peiran; WANG Rui; YANG Jing

doi:10.6039/j.issn.1001-0408.2024.24.03

您当前的位置：

首页 >

文章列表页 >

Mechanism of Gexia zhuyu decoction in the intervention of metabolic-associated fatty liver disease by inhibiting ferroptosis

更新时间：2025-09-24

- Mechanism of Gexia zhuyu decoction in the intervention of metabolic-associated fatty liver disease by inhibiting ferroptosis
- ZHONGGUO YAOFANG Vol. 35, Issue 24, Pages: 2977-2983(2024)
- 作者机构：
  
  1.黑龙江中医药大学基础医学院，哈尔滨　150040
  2.黑龙江中医药大学药学院，哈尔滨　150040
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.24.03
  CLC： R965;R285.5
- Received：13 May 2024，
  
  Revised：2024-11-03，
  
  Accepted：12 November 2024，
  
  Published：30 December 2024
- 稿件说明：
移动端阅览
赵玉强,王自有,李安琪,等.膈下逐瘀汤抑制铁死亡干预代谢相关脂肪性肝病的作用机制[J].中国药房,2024,35(24):2977-2983.

ZHAO Yuqiang,WANG Ziyou,LI Anqi,et al.Mechanism of Gexia zhuyu decoction in the intervention of metabolic-associated fatty liver disease by inhibiting ferroptosis[J].ZHONGGUO YAOFANG,2024,35(24):2977-2983.
赵玉强,王自有,李安琪,等.膈下逐瘀汤抑制铁死亡干预代谢相关脂肪性肝病的作用机制[J].中国药房,2024,35(24):2977-2983. DOI： 10.6039/j.issn.1001-0408.2024.24.03.

ZHAO Yuqiang,WANG Ziyou,LI Anqi,et al.Mechanism of Gexia zhuyu decoction in the intervention of metabolic-associated fatty liver disease by inhibiting ferroptosis[J].ZHONGGUO YAOFANG,2024,35(24):2977-2983. DOI： 10.6039/j.issn.1001-0408.2024.24.03.

摘要

目的

基于铁死亡角度探讨膈下逐瘀汤干预代谢相关脂肪性肝病（MAFLD）的潜在作用机制。

方法

借助网络药理学方法，筛选膈下逐瘀汤干预MAFLD铁死亡的中心靶点，并进行基因本体、京都基因和基因组数据库富集分析和分子对接。将发育正常的受精后3 d的斑马鱼幼鱼随机分为对照组、模型组（5 mmol/L硫代乙酰胺）、异甘草酸镁组（阳性对照，5 mg/mL）和膈下逐瘀汤低、中、高质量浓度组（20、40、80 μg/mL，以生药量计），培养72 h后检测其体内丙氨酸转氨酶（ALT）、天冬氨酸转氨酶（AST）、总

胆固醇（TC）、甘油三酯（TG）、丙二醛（MDA）、超氧化物歧化酶（SOD）、谷胱甘肽（GSH）、活性氧（ROS）、铁离子（Fe

）含量，观察其肝组织细胞结构和肝脏脂肪变性情况，检测其沉默信息调节因子1（SIRT1）、核转录因子红系2相关因子2（Nrf2）、谷胱甘肽过氧化物酶4（GPX4）蛋白的表达水平。

结果

膈下逐瘀汤潜在活性成分作用于MAFLD铁死亡的8个中心靶点包括肿瘤蛋白p53、SIRT1、Nrf2等；其富集于RNA聚合酶Ⅱ启动子转录的正/负向调控等生物过程，细胞核、细胞质等细胞成分，蛋白质结合等分子功能，以及铁死亡、癌症途径等信号通路，且可与主要活性成分紧密结合。与模型组比较，各药物组斑马鱼幼鱼体内ALT、AST、TC、TG、MDA、ROS、Fe

含量均显著降低，SOD、GSH含量均显著升高（

＜0.05），其肝组织细胞病理损伤情况均有所改善、肝脏脂质蓄积均有所减少，SIRT1、Nrf2、GPX4蛋白的表达均显著上调（

＜0.05）。

结论

膈下逐瘀汤可调节MAFLD模型斑马鱼幼鱼的脂质代谢，改善其氧化应激水平，维持其体内Fe

稳态，抑制其铁死亡进程，上述作用可能与激活SIRT1/Nrf2/GPX4轴有关。

Abstract

OBJECTIVE

To explore the potential mechanism of action of Gexia zhuyu decoction in the intervention of metabolic-associated fatty liver disease （MAFLD） based on ferroptosis.

METHODS

With the help of network pharmacology， the central targets of Gexia zhuyu decoction intervening in ferroptosis of MAFLD were screened， then gene ontology， Kyoto Encyclopedia Gene and Genomes enrichment analysis and molecular docking were performed. Juvenile zebrafish with normal development at 3 d post-fertilization were randomly divided into control group， model group （5 mmol/L thioacetamide）， magnesium isoglycyrrhizinate group （positive control， 5 mg/mL）， and Gexia zhuyu decoction low-， medium- and high- concentration groups （20， 40， 80 μg/mL， calculated by crude drugs）. After cultured for 72 h， the contents of alanine transaminase （ALT）， aspartate transaminase （AST）， total cholesterol （TC）， triglyceride （TG）， malondialdehyde （MDA）， superoxide dismutase （SOD）， glutathione （GSH）， reactive oxygen species （ROS） and Fe

were determined； the cellular structure of the liver tissues and hepatic steatosis were observed； the protein expression of silence information regulator 1 （SIRT1）， nuclear factor-erythroid 2-related factor 2 （Nrf2） and glutathione peroxidase 4

（GPX4） were detected.

RESULTS

The central targets of potential active ingredients of Gexia zhuyu decoction that act on ferroptosis in MAFLD included tumor proteins p53， SIRT1， Nrf2， etc.， which were enriched in biological processes such as positive/negative regulation of RNA polymerase Ⅱ promoter transcription， cellular components such as nucleus and cytoplasm， molecular functions such as protein binding， as well as signaling pathways such as ferroptosis and the cancer pathway， and they might be tightly linked to the main active ingredients. Compared with model group， the contents of ALT， AST， TC， TG， MDA， ROS and Fe

were all decreased significantly in each administration group， while the contents of SOD and GSH were increased significantly （

＜0.05）； the pathological damage of liver tissue cells had improved， and the accumulation of liver lipids had decreased. The protein expressions of SIRT1， Nrf2 and GPX4 had been significantly upregulated （

＜0.05）.

CONCLUSIONS

Gexia zhuyu decoction can regulate lipid metabolism， improve the level of oxidative stress， maintain Fe

homeostasis， and inhibit the process of ferroptosis in juvenile zebrafish with MAFLD， and the above effects may be related to the activation of the SIRT1/Nrf2/GPX4 axis.

关键词

Keywords

references

CANIVET C M ， BOURSIER J ， LOOMBA R . New nomenclature for nonalcoholic fatty liver disease：understanding metabolic dysfunction-associated steatotic liver disease，metabolic dysfunction- and alcohol-associated liver disease，and their implications in clinical practice [J ] . Semin Liver Dis ， 2024 ， 44 （ 1 ）： 35 - 42 .

CASTILLO-NÚÑEZ Y ， ALMEDA-VALDES P ， GONZÁLEZ-GÁLVEZ G ， et al . Metabolic dysfunction-associated steatotic liver disease and atherosclerosis [J ] . Curr Diab Rep ， 2024 ， 24 （ 7 ）： 158 - 166 .

CHAN W K ， WONG V W ， ADAMS L A ， et al . MAFLD in adults：non-invasive tests for diagnosis and monitoring of MAFLD [J ] . Hepatol Int ， 2024 ， 18 （ Suppl. 2 ）： 909 - 921 .

石玲，曹亚芳，孙青凤 . 膈下逐瘀汤联合中医外治法治疗子宫内膜异位症继发痛经（气滞血瘀型）的临床疗效观察 [J ] . 时珍国医国药， 2023 ， 34 （ 5 ）： 1147 - 1150 .

SHI L ， CAO Y F ， SUN Q F . Clinical observation of Gexia zhuyu decoction combined with external treatment of traditional Chinese medicine on dysmenorrhea secondary to endometriosis（qi stagnation and blood stasis type） [J ] . Lishizhen Med Mater Med Res ， 2023 ， 34 （ 5 ）： 1147 - 1150 .

孙旭，熊芬，黄育生，等 . 膈下逐瘀汤对四氯化碳诱导的肝纤维化大鼠Wnt/β-catenin通路的影响 [J ] . 中成药， 2022 ， 44 （ 6 ）： 1945 - 1950 .

SUN X ， XIONG F ， HUANG Y S ， et al . Effect of Gexia zhuyu decoction on Wnt/β-catenin pathway in rats with hepatic fibrosis induced by carbon tetrachloride [J ] . Chin Tradit Pat Med ， 2022 ， 44 （ 6 ）： 1945 - 1950 .

VINIK Y ， MAIMON A ， DUBEY V ， et al . Programming a ferroptosis-to-apoptosis transition landscape revealed ferroptosis biomarkers and repressors for cancer therapy [J ] . Adv Sci ， 2024 ， 11 （ 17 ）： e2307263 .

LIU S H ， GAO Z S ， HE W Q ， et al . The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD [J ] . Free Radic Biol Med ， 2022 ，193（Pt. 1 ）： 213 - 226 .

杨婧，贾彦，王蔚，等 . 膈下逐瘀汤对大鼠纤维化肝脏组织谷胱甘肽抗氧化系统的影响 [J ] . 中国实验方剂学杂志， 2017 ， 23 （ 17 ）： 121 - 126 .

YANG J ， JIA Y ， WANG W ， et al . Effects of Gexia zhuyutang on glutathione antioxidant system in liver tissue of rat with hepatic fibrosis [J ] . Chin J Exp Tradit Med Formulae ， 2017 ， 23 （ 17 ）： 121 - 126 .

ZHANG Y P ， YUAN T H ， LI Y S ， et al . Network pharmacology analysis of the mechanisms of compound herba sarcandrae（Fufang zhongjiefeng）aerosol in chronic pharyn-gitis treatment [J ] . Drug Des Devel Ther ， 2021 ， 15 ： 2783 - 2803 .

冯海童，祁玉麟，冯雅雯，等 . 基于网络药理学、分子对接及实验验证探讨滋肾健脾化瘀片对糖尿病视网膜病变的干预机制 [J ] . 中药新药与临床药理， 2024 ， 35 （ 8 ）： 1197 - 1205 .

FENG H T ， QI Y L ， FENG Y W ， et al . Exploring the intervention mechanism of Zishen jianpi huayu tablets on diabetic retinopathy based on network pharmacology，molecular docking and experimental validation [J ] . Tradit Chin Drug Res Clin Pharmacol ， 2024 ， 35 （ 8 ）： 1197 - 1205 .

DENG S H ， LI J ， LI L ， et al . Quercetin alleviates lipopolysaccharide-induced acute lung injury by inhibiting ferroptosis via the Sirt1/Nrf2/Gpx4 pathway [J ] . Int J Mol Med ， 2023 ， 52 （ 6 ）： 118 .

林丽婷，王继森，高天慧，等 . 蓬莪术醋制前后改善斑马鱼急性肝损伤的作用机制研究 [J ] . 中草药， 2024 ， 55 （ 8 ）： 2611 - 2619 .

LIN L T ， WANG J S ， GAO T H ， et al . Mechanism of raw and vinegar-processed Curcuma phaeocaulis on impro-ving acute liver injury in zebrafish [J ] . Chin Tradit Herb Drugs ， 2024 ， 55 （ 8 ）： 2611 - 2619 .

WU Y J ， ZHANG X L ， CHEN J J ， et al . Self-recovery study of fluoride-induced ferroptosis in the liver of zebra-fish（ Danio rerio ） [J ] . Aquat Toxicol ， 2022 ， 251 ： 106275 .

GAO P ， CHANG C ， LIANG J L ， et al . Embryonic amoxicillin exposure has limited impact on liver development but increases susceptibility to NAFLD in zebrafish larvae [J ] . Int J Mol Sci ， 2024 ， 25 （ 5 ）： 2744 .

TONON F ， FARRA R ， ZENNARO C ， et al . Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules [J ] . Pharmaceuticals ， 2021 ， 14 （ 8 ）： 803 .

李杨，刘丽 . 基于网络药理学探讨膈下逐瘀汤加减方治疗慢性盆腔炎性疾病的作用机制 [J ] . 世界中西医结合杂志， 2021 ， 16 （ 10 ）： 1858 - 1864 .

LI Y ， LIU L . The mechanism study of the treatment with chronic pelvic inflammatory diseases by modified Gexia zhuyu decoction based on the network pharmacology and molecular docking technology [J ] . World J Integr Tradit West Med ， 2021 ， 16 （ 10 ）： 1858 - 1864 .

BOTROS S R ， MATOUK A I ， AMIN A ， et al . Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats：the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways [J ] . Front Pharmacol ， 2024 ， 15 ： 1353029 .

XIE W X ， DENG L ， QIAN R ， et al . Curculigoside atte-nuates endoplasmic reticulum stress-induced epithelial cell and fibroblast senescence by regulating the SIRT1-P300 signaling pathway [J ] . Antioxidants（Basel）， 2024 ， 13 （ 4 ）： 420 .

XUE P P ， ZHUANG H L ， BAI T J ， et al . Iron（Ⅱ）-based metal-organic framework nanozyme for boosting tumor ferroptosis through inhibiting DNA damage repair and system Xc [J ] . J Nanobiotechnology ， 2024 ， 22 （ 1 ）： 228 .

BADGLEY M A ， KREMER D M ， MAURER H C ， et al . Cysteine depletion induces pancreatic tumor ferroptosis in mice [J ] . Science ， 2020 ， 368 （ 6486 ）： 85 - 89 .

Views

121

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on mechanism of Chanbao zhichuang suppository in treating hemorrhoids based on network pharmacology and metabolomics

Mechanism of joint injection of Caulophyllum robustum Maxim in the treatment of rheumatoid arthritis

试析新药研发过程中的转化研究链

系统药理学研究方法在中药不良反应研究中的应用进展

Q-marker analysis of Kanggongyan soft capsule

Related Author

LU Fang

XIE Chunxiang

LIU Shumin

CHENG Ruyang

JIANG Xin

GUO Chunfeng

KUANG Haixue

GUO Yuyan

Related Institution

Dept. of TCM Internal Medicine， Hanan Branch of Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

Institute of Traditional Chinese Medicine，Heilongjiang University of Chinese Medicine

Heilongjiang Chanbao Biotechnology Development Co.， Ltd.

Key Laboratory of Basic and Applied Research of Northern Medicine， Ministry of Education， Heilongjiang University of Chinese Medicine/Heilongjiang Provincial Key Laboratory of Pharmacodynamic Substances of Traditional Chinese Medicine and Natural Medicine

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰